| LGE positive (n = 19) | LGE negative (n = 8) | p value |
---|---|---|---|
Clinical and laboratorial features | Â | Â | Â |
Age, years | 43.8 ± 12.4 | 48.9 ± 13.2 | n.s. |
SLE duration, years | 13.6 ± 5.1 | 15.2 ± 10.6 | n.s. |
SLEDAI score (>4), no. (%) | 5 (26) | 0 (0) | n.s. |
Cardiovascular symptoms, no. (%) | 4 (21) | 4 (50) | n.s. |
Antiphospholipid syndrome, no. (%) | 5 (26) | 1 (12.5) | n.s. |
Anti-ds DNA antibodies (10 µl/l), no. (%) | 14 (74) | 6 (75) | n.s. |
CRP* (>2 mg/l), no.(%) | 12 (63) | 1 (12.5) | 0.03 |
MDRD** (ml/min/1.73 m2) | 81.1 ± 39.3 | 65.3 ± 27.7 | n.s. |